Reuters Health: COVID vaccine proved safe, well tolerated in patients with rheumatic diseases

UC expert recommends further study differentiates between treatment, disease types

A new European study recently published in the Annals of Rheumatic Diseases shows that currently available COVID-19 vaccines rarely cause flares in patients with rheumatic and musculoskeletal disease. Flares were reported in less than 5% of all cases within the study.

While encouraging, Wenhai Shao, PhD, associate professor in the Division of Immunology, Allergy and Rheumatology in the University of Cincinnati's Department of Internal Medicine, told Reuters Health that further studies should differentiate whether patients are taking immunosuppressants or other types of drugs, compare to healthy individuals and note the severity of the rheumatic or musculoskeletal diseases when the vaccination was given for more specific results.

"A bioinformatics approach could be used to analyze the data in these different ways," Shao said.

Read the Reuters Health article.

Featured photo at top of vaccination courtesy of 

Related Stories


Gen Z is romanticizing in-person work

July 19, 2024

Many members of Gen Z are romanticizing office jobs as they gain in-person positions for the first time following years of remote work becoming more of a norm, PopSugar reported. Nadia Ibrahim-Taney, an assistant professor – educator and assistant director in career services at the University of Cincinnati's Carl H. Lindner College of Business, says it's normal and healthy for young workers to glamorize going to work.


UC study examines impact of incarceration on youth health

July 19, 2024

Samantha Boch, PhD, at the UC College onf Nursing, has studied the impact of incarceration on child and family health for more than a decade. Her latest research examines youth health in Cincinnati and relies on collaboration with Cincinnati Children's Hospital.

Debug Query for this